

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.07614037 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.02637514 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.94128331 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.94128331 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.82615710 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.66980510 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.33826597 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.33826597 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.33826597 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.33826597 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.33826597 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.33826597 |
| 13 | detection of other organism (GO:0098543) | 5.02737310 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.99588480 |
| 15 | detection of bacterium (GO:0016045) | 4.90361434 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81683268 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.74045173 |
| 18 | response to peptidoglycan (GO:0032494) | 4.47570345 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.35016007 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.29483091 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.18927698 |
| 22 | cellular response to type I interferon (GO:0071357) | 4.15103353 |
| 23 | type I interferon signaling pathway (GO:0060337) | 4.15103353 |
| 24 | response to type I interferon (GO:0034340) | 4.11767893 |
| 25 | leukocyte aggregation (GO:0070486) | 4.01669661 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99178132 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 3.82108525 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72940255 |
| 29 | neutrophil activation (GO:0042119) | 3.67999879 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66193212 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.63908582 |
| 32 | detection of biotic stimulus (GO:0009595) | 3.63729065 |
| 33 | respiratory burst (GO:0045730) | 3.61442679 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.61114180 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58008545 |
| 36 | response to host immune response (GO:0052572) | 3.54189343 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54189343 |
| 38 | granulocyte activation (GO:0036230) | 3.48665003 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48160645 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.47684628 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.42019608 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41488243 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40037840 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39085042 |
| 45 | cellular extravasation (GO:0045123) | 3.32596956 |
| 46 | response to host (GO:0075136) | 3.32052794 |
| 47 | response to host defenses (GO:0052200) | 3.32052794 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32052794 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30941532 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.28312003 |
| 51 | B cell mediated immunity (GO:0019724) | 3.28106821 |
| 52 | macrophage activation (GO:0042116) | 3.26465612 |
| 53 | microglial cell activation (GO:0001774) | 3.26080106 |
| 54 | germinal center formation (GO:0002467) | 3.24889133 |
| 55 | response to interleukin-15 (GO:0070672) | 3.22971942 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21640175 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.20203736 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18968082 |
| 59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17186619 |
| 60 | defense response to protozoan (GO:0042832) | 3.16946851 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14679395 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.13539214 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.11716104 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11578551 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10879426 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09073287 |
| 67 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07470132 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04900033 |
| 69 | dendritic cell chemotaxis (GO:0002407) | 3.04333110 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00928347 |
| 71 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94943919 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92782683 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 2.92184704 |
| 74 | negative regulation of innate immune response (GO:0045824) | 2.91621775 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 2.91096314 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.89706826 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 2.89529355 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.88302091 |
| 79 | response to interferon-alpha (GO:0035455) | 2.88017571 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86486730 |
| 81 | negative regulation of type 2 immune response (GO:0002829) | 2.85142891 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.84564365 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 2.84342988 |
| 84 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83623517 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82894802 |
| 86 | T-helper 1 type immune response (GO:0042088) | 2.81975188 |
| 87 | regulation of cellular extravasation (GO:0002691) | 2.81628698 |
| 88 | dendritic cell migration (GO:0036336) | 2.81561931 |
| 89 | neutrophil mediated immunity (GO:0002446) | 2.81524116 |
| 90 | regulation of type 2 immune response (GO:0002828) | 2.81395920 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.80512954 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.79753277 |
| 93 | response to protozoan (GO:0001562) | 2.78292579 |
| 94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.75103877 |
| 95 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.75103877 |
| 96 | cellular response to interferon-gamma (GO:0071346) | 2.72458036 |
| 97 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.71642796 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68782694 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68772186 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.68603676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.27175089 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.36391555 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08974040 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.56314411 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07985093 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95184054 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92446985 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80280538 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67067954 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66926684 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60355444 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52824232 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.49820956 |
| 14 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42508321 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35944036 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.34361814 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25632810 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24058678 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23823157 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22137078 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17543677 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11973218 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.08738574 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03530506 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99662020 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98959854 |
| 27 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98424216 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97050915 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94551348 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87266451 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84440990 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84215066 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81189021 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76290648 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.75599086 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74801273 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72836606 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72117686 |
| 39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.70149080 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68290391 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65596499 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64967253 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63102510 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61451486 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57379472 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55534657 |
| 47 | * MYB_26560356_Chip-Seq_TH1_Human | 1.55341457 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.54157020 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52514193 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52388328 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45190773 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39270785 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34200306 |
| 54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31370244 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30592603 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29770774 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29570933 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29423570 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29215012 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28727755 |
| 61 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25980971 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25901996 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25341729 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24269158 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22746406 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21467358 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20323772 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20305093 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19903671 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18150155 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16011859 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15766087 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15661564 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13204406 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11045654 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09793104 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09684896 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09164980 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08485773 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08454074 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07608384 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07295291 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06561825 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06008110 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04367520 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03530998 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01945376 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00819693 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00740055 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99323921 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96288414 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92055423 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88739873 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88538656 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87990065 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87684469 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87568091 |
| 98 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.87563968 |
| 99 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.84880357 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84813607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.88050532 |
| 2 | MP0003436_decreased_susceptibility_to | 4.17605543 |
| 3 | MP0003303_peritoneal_inflammation | 3.87210679 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.56055481 |
| 5 | MP0006082_CNS_inflammation | 3.07314382 |
| 6 | MP0009785_altered_susceptibility_to | 3.02671654 |
| 7 | MP0002419_abnormal_innate_immunity | 2.93810726 |
| 8 | MP0005025_abnormal_response_to | 2.85965096 |
| 9 | MP0005387_immune_system_phenotype | 2.83890622 |
| 10 | MP0001790_abnormal_immune_system | 2.83890622 |
| 11 | MP0005671_abnormal_response_to | 2.66916634 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.66714929 |
| 13 | MP0000685_abnormal_immune_system | 2.61675850 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.58841555 |
| 15 | MP0001800_abnormal_humoral_immune | 2.55070873 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.47954912 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.37547257 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.36291501 |
| 19 | MP0002723_abnormal_immune_serum | 2.35902874 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.32265778 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.28758413 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.21149025 |
| 23 | MP0001819_abnormal_immune_cell | 2.20631513 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.11200266 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.90168243 |
| 26 | MP0004510_myositis | 1.85792498 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.84559263 |
| 28 | MP0008260_abnormal_autophagy | 1.83125850 |
| 29 | MP0004947_skin_inflammation | 1.80998209 |
| 30 | MP0005451_abnormal_body_composition | 1.79175526 |
| 31 | MP0002405_respiratory_system_inflammati | 1.77028000 |
| 32 | MP0003866_abnormal_defecation | 1.72022601 |
| 33 | MP0009840_abnormal_foam_cell | 1.64673463 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.64218431 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.63368534 |
| 36 | MP0008469_abnormal_protein_level | 1.60468981 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.60358055 |
| 38 | MP0000716_abnormal_immune_system | 1.59575980 |
| 39 | MP0009764_decreased_sensitivity_to | 1.59141858 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.55778515 |
| 41 | MP0002398_abnormal_bone_marrow | 1.48178745 |
| 42 | MP0003075_altered_response_to | 1.47299843 |
| 43 | MP0009278_abnormal_bone_marrow | 1.44280946 |
| 44 | MP0000858_altered_metastatic_potential | 1.44228883 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.43188929 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.39815269 |
| 47 | MP0005360_urolithiasis | 1.39417701 |
| 48 | MP0005310_abnormal_salivary_gland | 1.39334191 |
| 49 | MP0002132_abnormal_respiratory_system | 1.37108037 |
| 50 | MP0003828_pulmonary_edema | 1.36725735 |
| 51 | MP0005166_decreased_susceptibility_to | 1.34941705 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.31878694 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.25524961 |
| 54 | MP0002429_abnormal_blood_cell | 1.23189980 |
| 55 | MP0002722_abnormal_immune_system | 1.22059519 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.20850197 |
| 57 | MP0003448_altered_tumor_morphology | 1.18259686 |
| 58 | MP0004858_abnormal_nervous_system | 1.17923993 |
| 59 | MP0000490_abnormal_crypts_of | 1.17755570 |
| 60 | MP0008004_abnormal_stomach_pH | 1.17258708 |
| 61 | MP0004883_abnormal_blood_vessel | 1.16192466 |
| 62 | MP0000343_altered_response_to | 1.16007689 |
| 63 | MP0001873_stomach_inflammation | 1.13653371 |
| 64 | MP0000604_amyloidosis | 1.08510458 |
| 65 | MP0005164_abnormal_response_to | 1.07870189 |
| 66 | MP0001663_abnormal_digestive_system | 1.06890622 |
| 67 | MP0001851_eye_inflammation | 1.06320728 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.05557434 |
| 69 | MP0005390_skeleton_phenotype | 1.04047058 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.01674017 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.01674017 |
| 72 | MP0003690_abnormal_glial_cell | 0.98113837 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.93772156 |
| 74 | MP0009763_increased_sensitivity_to | 0.86790671 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.86636381 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 0.84216201 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.81886909 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.80944010 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 0.80213605 |
| 80 | MP0001853_heart_inflammation | 0.79664438 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.77179009 |
| 82 | MP0002933_joint_inflammation | 0.74268699 |
| 83 | MP0003795_abnormal_bone_structure | 0.74110240 |
| 84 | MP0005365_abnormal_bile_salt | 0.71058271 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.70996602 |
| 86 | MP0003045_fibrosis | 0.70535141 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 0.70304406 |
| 88 | MP0000249_abnormal_blood_vessel | 0.70255677 |
| 89 | MP0006054_spinal_hemorrhage | 0.69719605 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.69631892 |
| 91 | MP0001958_emphysema | 0.69390313 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.68398508 |
| 93 | MP0003091_abnormal_cell_migration | 0.67542811 |
| 94 | MP0002254_reproductive_system_inflammat | 0.64028132 |
| 95 | MP0008874_decreased_physiological_sensi | 0.63094616 |
| 96 | MP0004381_abnormal_hair_follicle | 0.62816525 |
| 97 | MP0001542_abnormal_bone_strength | 0.62118758 |
| 98 | MP0003329_amyloid_beta_deposits | 0.58794211 |
| 99 | MP0005023_abnormal_wound_healing | 0.57080809 |
| 100 | MP0000609_abnormal_liver_physiology | 0.56808966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.67435223 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.51218253 |
| 3 | Myositis (HP:0100614) | 5.51170106 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.47505199 |
| 5 | Orchitis (HP:0100796) | 5.37482192 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.36488526 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.77989447 |
| 8 | Optic neuritis (HP:0100653) | 4.77989447 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.52128312 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.33134682 |
| 11 | Stomatitis (HP:0010280) | 4.15692386 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.86654359 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.82475152 |
| 14 | Obstructive lung disease (HP:0006536) | 3.80074329 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80074329 |
| 16 | Gingivitis (HP:0000230) | 3.62000810 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.60824496 |
| 18 | Meningitis (HP:0001287) | 3.51602958 |
| 19 | Recurrent skin infections (HP:0001581) | 3.44816867 |
| 20 | Spontaneous hematomas (HP:0007420) | 3.44377602 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.42854399 |
| 22 | Increased IgE level (HP:0003212) | 3.42804155 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.40638549 |
| 24 | Encephalitis (HP:0002383) | 3.35259684 |
| 25 | Malnutrition (HP:0004395) | 3.32862426 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.32410561 |
| 27 | Vasculitis (HP:0002633) | 3.32055637 |
| 28 | Urticaria (HP:0001025) | 3.24420549 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.13083212 |
| 30 | Peritonitis (HP:0002586) | 3.07449481 |
| 31 | Cellulitis (HP:0100658) | 3.01319732 |
| 32 | Amyloidosis (HP:0011034) | 2.99617798 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.93007080 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.93007080 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 2.93007080 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.92815680 |
| 37 | Hemoptysis (HP:0002105) | 2.91899549 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90431509 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90431509 |
| 40 | Petechiae (HP:0000967) | 2.88027732 |
| 41 | Chest pain (HP:0100749) | 2.79399182 |
| 42 | Episodic fever (HP:0001954) | 2.78847941 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.77769790 |
| 44 | Loss of speech (HP:0002371) | 2.76948174 |
| 45 | Hypochromic anemia (HP:0001931) | 2.71648516 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.61540329 |
| 47 | Increased IgM level (HP:0003496) | 2.59612954 |
| 48 | Pustule (HP:0200039) | 2.56811918 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.56021329 |
| 50 | Anorexia (HP:0002039) | 2.53574574 |
| 51 | Purpura (HP:0000979) | 2.53540442 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.50827868 |
| 53 | Gingival bleeding (HP:0000225) | 2.49943112 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.49165577 |
| 55 | Leukocytosis (HP:0001974) | 2.44803244 |
| 56 | Recurrent viral infections (HP:0004429) | 2.44576720 |
| 57 | Pulmonary embolism (HP:0002204) | 2.40318004 |
| 58 | Arterial thrombosis (HP:0004420) | 2.38438606 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.37275526 |
| 60 | Premature loss of primary teeth (HP:0006323) | 2.35704009 |
| 61 | Osteomyelitis (HP:0002754) | 2.34962338 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.33704169 |
| 63 | T lymphocytopenia (HP:0005403) | 2.32216274 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.31622048 |
| 65 | Epistaxis (HP:0000421) | 2.26317659 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.25678194 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.19897381 |
| 68 | Abnormality of the peritoneum (HP:0002585) | 2.19412208 |
| 69 | Colitis (HP:0002583) | 2.16943405 |
| 70 | Nasal polyposis (HP:0100582) | 2.16276453 |
| 71 | Gangrene (HP:0100758) | 2.15564161 |
| 72 | Increased serum ferritin (HP:0003281) | 2.15430389 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.13790624 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.10877930 |
| 75 | Disinhibition (HP:0000734) | 2.07083759 |
| 76 | Abnormality of T cells (HP:0002843) | 2.06438084 |
| 77 | Sepsis (HP:0100806) | 2.06109736 |
| 78 | Acne (HP:0001061) | 2.05683258 |
| 79 | Lymphopenia (HP:0001888) | 2.05172408 |
| 80 | Chronic otitis media (HP:0000389) | 2.04755738 |
| 81 | Granulocytopenia (HP:0001913) | 2.04123226 |
| 82 | Glomerulopathy (HP:0100820) | 2.02339226 |
| 83 | Microcytic anemia (HP:0001935) | 2.01821084 |
| 84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00979198 |
| 85 | Chronic diarrhea (HP:0002028) | 2.00869090 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 2.00716661 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00464474 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97322228 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.97317305 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.96043213 |
| 91 | Skin ulcer (HP:0200042) | 1.94432962 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 1.94172498 |
| 93 | Polycythemia (HP:0001901) | 1.92420066 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90547047 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90547047 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90547047 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 1.90234841 |
| 98 | Emphysema (HP:0002097) | 1.88999166 |
| 99 | Recurrent pneumonia (HP:0006532) | 1.88720495 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.88696753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.25992515 |
| 2 | ERN1 | 4.05867989 |
| 3 | MAP4K1 | 3.41070469 |
| 4 | TYK2 | 3.12345868 |
| 5 | IRAK4 | 2.99521804 |
| 6 | MAP2K3 | 2.71690639 |
| 7 | BLK | 2.68972715 |
| 8 | CSK | 2.57092668 |
| 9 | EPHB1 | 2.32336471 |
| 10 | PRPF4B | 2.24011477 |
| 11 | TAOK1 | 2.19920262 |
| 12 | GRK6 | 2.09252900 |
| 13 | TNK2 | 2.04836830 |
| 14 | MAP3K3 | 2.03780732 |
| 15 | ZAP70 | 2.03498782 |
| 16 | MAP3K11 | 1.98082775 |
| 17 | FES | 1.91362132 |
| 18 | JAK3 | 1.86518134 |
| 19 | TBK1 | 1.76162075 |
| 20 | FGR | 1.66343837 |
| 21 | IKBKE | 1.60775558 |
| 22 | MAP3K14 | 1.59061390 |
| 23 | BTK | 1.50647734 |
| 24 | HCK | 1.49608056 |
| 25 | TXK | 1.44431987 |
| 26 | RIPK1 | 1.41909518 |
| 27 | MAP3K1 | 1.41362810 |
| 28 | JAK1 | 1.37712152 |
| 29 | TRIB3 | 1.35091730 |
| 30 | SYK | 1.32499216 |
| 31 | SIK3 | 1.31432461 |
| 32 | TAOK2 | 1.30618562 |
| 33 | JAK2 | 1.28175356 |
| 34 | TESK2 | 1.25772177 |
| 35 | MATK | 1.25767184 |
| 36 | LYN | 1.20635123 |
| 37 | FGFR4 | 1.18861014 |
| 38 | CDC42BPA | 1.17313154 |
| 39 | PTK6 | 1.17214420 |
| 40 | MAP3K13 | 1.15141350 |
| 41 | KIT | 1.13132853 |
| 42 | PRKD2 | 1.12891771 |
| 43 | KSR2 | 1.10187222 |
| 44 | TGFBR2 | 1.07075853 |
| 45 | CSF1R | 1.04924281 |
| 46 | LCK | 1.03710567 |
| 47 | IRAK3 | 1.01236105 |
| 48 | SMG1 | 1.00656387 |
| 49 | PRKG2 | 0.93887017 |
| 50 | MARK2 | 0.92290131 |
| 51 | IRAK1 | 0.91952785 |
| 52 | IKBKB | 0.89708696 |
| 53 | YES1 | 0.89442620 |
| 54 | ACVR1B | 0.88988750 |
| 55 | SIK1 | 0.88911608 |
| 56 | GRK7 | 0.85907242 |
| 57 | PDPK1 | 0.85600792 |
| 58 | EPHA3 | 0.83791001 |
| 59 | PDK1 | 0.80103805 |
| 60 | MAP3K6 | 0.77100278 |
| 61 | MARK3 | 0.76223584 |
| 62 | IRAK2 | 0.75883879 |
| 63 | ITK | 0.68919013 |
| 64 | STK10 | 0.66364691 |
| 65 | BMPR2 | 0.65302711 |
| 66 | SIK2 | 0.64984818 |
| 67 | FYN | 0.64187596 |
| 68 | DYRK1B | 0.63811753 |
| 69 | FGFR3 | 0.62610532 |
| 70 | MAPK7 | 0.58173430 |
| 71 | TAOK3 | 0.57190924 |
| 72 | LRRK2 | 0.56890155 |
| 73 | HIPK2 | 0.56847698 |
| 74 | MAP3K2 | 0.56585979 |
| 75 | MAP3K5 | 0.54002686 |
| 76 | MAP3K7 | 0.52262081 |
| 77 | CDK19 | 0.51510086 |
| 78 | RPS6KL1 | 0.49089911 |
| 79 | RPS6KC1 | 0.49089911 |
| 80 | MAP2K6 | 0.47836800 |
| 81 | TEC | 0.46826805 |
| 82 | MAPK12 | 0.42625785 |
| 83 | STK38 | 0.42332006 |
| 84 | BMX | 0.41656606 |
| 85 | PAK4 | 0.41276500 |
| 86 | MAPKAPK2 | 0.41050544 |
| 87 | TESK1 | 0.40679748 |
| 88 | DDR2 | 0.39801953 |
| 89 | MOS | 0.39563179 |
| 90 | RPS6KA6 | 0.38430672 |
| 91 | RET | 0.37983054 |
| 92 | PTK2B | 0.37948511 |
| 93 | MAP2K4 | 0.35928859 |
| 94 | STK11 | 0.34562129 |
| 95 | PRKCD | 0.34270354 |
| 96 | PIM1 | 0.33509271 |
| 97 | MAP2K2 | 0.33354207 |
| 98 | MAP3K8 | 0.32592080 |
| 99 | PRKCQ | 0.32205998 |
| 100 | RPS6KA2 | 0.31970269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.03210881 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91296326 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.90925941 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.61012758 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53403515 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36471495 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20201658 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.08113793 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06712988 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90386567 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88301204 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.87291328 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84267257 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.81004445 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80878976 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79692746 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79407340 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66732647 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.64355391 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.63471700 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62920572 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62107507 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61560602 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58838454 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55348105 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.54175676 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.51772898 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49287032 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46170175 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45397538 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43586793 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.43301656 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42958049 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.40658034 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40373189 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31849738 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.31401541 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27087049 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.26174813 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21060616 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16920839 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16597414 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.15456521 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13521822 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.12762102 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.98455044 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.94899313 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93244719 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93211488 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88547678 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85863620 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85570887 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85444363 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.83564151 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79615472 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.78056751 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76918120 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.76520885 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76442984 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74074686 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.73884414 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72777701 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71306813 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70852427 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70834476 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70521567 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69026422 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68740170 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65006934 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60758349 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57825888 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57353815 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56045707 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53983884 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52679646 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50203106 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.49984699 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49491552 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49161297 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48747937 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48439868 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47952116 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.45747932 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42454842 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42272073 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42025345 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41217412 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40775984 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.38947762 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38170017 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37478260 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35884514 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34770430 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34469038 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.33473484 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33125983 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31908706 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29605502 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29089971 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28589232 |

